Application 018029
- Type
- NDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RITALIN-SR | METHYLPHENIDATE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018029-001 | RITALIN-SR | METHYLPHENIDATE HYDROCHLORIDE | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N018029-001 | RITALIN-SR | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N018029-001 | RITALIN-SR | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N018029-001 | RITALIN-SR | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N018029-001 | RITALIN-SR | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N018029-001 | RITALIN-SR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1982-03-30 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Lupin Pharmaceuticals,Inc. | 57fd619e-687d-403c-a77a-3dc3a1bab65a | 2023-12-11 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Lupin Pharmaceuticals,Inc. | 5bfe50ed-171f-4c40-bc0b-20c68e8e2025 | 2023-12-11 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Eywa Pharma Inc | 298fb86d-7d94-49e1-b743-3e7801122422 | 2023-11-08 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylin | METHYLPHENIDATE HYDROCHLORIDE | SHIONOGI INC. | 9e3c22d9-71d9-46a7-b315-8021c94c4bec | 2023-11-01 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | SpecGx LLC | 981a2ad8-33f7-4678-9162-9df9685bd4a6 | 2023-10-01 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | XLCare Pharmaceuticals, Inc. | 91833146-fa95-471a-8b8d-6d36a2db5c9a | 2023-09-28 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Camber Pharmaceuticals Inc. | bb73cd3e-aa7c-4f7e-826d-75e71fb6d1e0 | 2023-09-27 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| METHYLPHENIDATE HYDROCHLORIDE | METHYLPHENIDATE HYDROCHLORIDE | QUAGEN PHARMACEUTICALS LLC | 59de488c-c3f8-415d-9e9f-9102c090aac8 | 2023-02-02 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Ascend Laboratories, LLC | 5fa3da25-13aa-4ee3-acf5-cd505f4688d0 | 2021-12-29 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Dr.Reddys Laboratories Inc | 7124df7e-6273-a68d-6e35-dc06122d8686 | 2021-12-03 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| METHYLPHENIDATE HYDROCHLORIDE | METHYLPHENIDATE HYDROCHLORIDE | XLCare Pharmaceuticals Inc | 94dc74d4-b4ef-45bc-b502-54ec692e9bd5 | 2021-08-18 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | b9af3104-172d-4975-9301-b9fe7db9ef12 | 2021-08-17 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | XLCare Pharmaceuticals, Inc. | b07150db-fd99-4400-bb83-b3a7544a917a | 2021-08-17 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Ascent Pharmaceuticals, Inc. | 45ebb59c-9603-4df6-b1be-3295ba2db1e7 | 2021-01-29 | Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 60990 | SUPPL | 2019-11-20 |
| 60989 | SUPPL | 2019-11-20 |
| 60983 | SUPPL | 2019-11-20 |
| 57267 | SUPPL | 2019-01-18 |
| 57266 | SUPPL | 2019-01-18 |
| 57188 | SUPPL | 2019-01-11 |
| 57187 | SUPPL | 2019-01-11 |
| 57186 | SUPPL | 2019-01-11 |
| 57185 | SUPPL | 2019-01-11 |
| 46826 | SUPPL | 2017-01-13 |
| 46825 | SUPPL | 2017-01-13 |
| 46706 | SUPPL | 2017-01-06 |
| 11125 | SUPPL | 2015-04-21 |
| 799 | SUPPL | 2015-04-21 |
| 33401 | SUPPL | 2013-12-17 |
| 13987 | SUPPL | 2013-12-16 |
| 13986 | SUPPL | 2013-06-11 |
| 11124 | SUPPL | 2013-06-11 |
| 798 | SUPPL | 2010-12-15 |
| 11123 | SUPPL | 2010-12-10 |
| 797 | SUPPL | 2010-11-18 |
| 33400 | SUPPL | 2010-11-17 |
| 44018 | ORIG | 2007-05-10 |
| 33399 | SUPPL | 2007-05-01 |
| 796 | SUPPL | 2007-05-01 |
| 13985 | SUPPL | 2006-08-11 |
| 795 | SUPPL | 2006-08-11 |
| 33398 | SUPPL | 2006-08-09 |
| 11122 | SUPPL | 2006-08-09 |
| 793 | SUPPL | 2004-05-27 |
| 792 | SUPPL | 2004-05-27 |
| 794 | SUPPL | 2002-01-11 |